BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2702343)

  • 1. [Principles and perspectives of immunomodulation in the treatment of diabetes mellitus type I].
    Majkowska L; Czekalski S
    Pol Tyg Lek; 1989 May 22-29; 44(21-22):509-12. PubMed ID: 2702343
    [No Abstract]   [Full Text] [Related]  

  • 2. [The characteristics of the immunogenesis and immunocorrection of diabetes mellitus].
    Galenok VA; Zhuk EA
    Ter Arkh; 1995; 67(10):7-12. PubMed ID: 8779114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunomodulating therapy in insulin-dependent diabetes mellitus: problems and new prospects].
    Galenok VA; Zhuk EA
    Ter Arkh; 1995; 67(12):80-4. PubMed ID: 8820069
    [No Abstract]   [Full Text] [Related]  

  • 4. Prevention and treatment of type I diabetes in NOD mice by linomide.
    Slavin S; Gross D; Weiss L
    Transplant Proc; 1995 Dec; 27(6):3240. PubMed ID: 8539933
    [No Abstract]   [Full Text] [Related]  

  • 5. [Immune modulation therapy in type I diabetes mellitus].
    Schmeidl R; Teuber J; Paschke R; Schwedes U; Usadel KH
    Fortschr Med; 1986 Dec; 104(45):879-83. PubMed ID: 3542769
    [No Abstract]   [Full Text] [Related]  

  • 6. [Immunointervention in type 1 diabetes mellitus].
    Vialettes B
    Diabete Metab; 1992; 18(1):3-10; discussion 11-3. PubMed ID: 1563533
    [No Abstract]   [Full Text] [Related]  

  • 7. [Thymogen in the treatment of type-1 diabetes mellitus].
    Zhuk EA; Galenok VA
    Ter Arkh; 1996; 68(10):12-4. PubMed ID: 9026934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outlook for immune intervention in type I diabetes.
    Grob PJ
    Curr Probl Clin Biochem; 1983; 12():119-40. PubMed ID: 6360542
    [No Abstract]   [Full Text] [Related]  

  • 9. Controversies on the prevention of insulin-dependent diabetes mellitus by immunomodulation: lessons from NOD mice treated with beta-1,6;1,3-D-glucan and rhIGF-I.
    Kida K; Kaino Y; Ito T; Hirai H
    J Pediatr Endocrinol Metab; 1998 Apr; 11 Suppl 2():327-33. PubMed ID: 9642663
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunologic "vaccination" for the prevention of autoimmune diabetes (type 1A).
    Simone EA; Wegmann DR; Eisenbarth GS
    Diabetes Care; 1999 Mar; 22 Suppl 2():B7-15. PubMed ID: 10097893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preventing type 1 diabetes may someday become possible.
    Vastag B
    JAMA; 2002 Feb; 287(6):701-2. PubMed ID: 11851514
    [No Abstract]   [Full Text] [Related]  

  • 12. [Systemic autoantibodies and their correction in patients with diabetic retinopathy in type 1 diabetes mellitus].
    Teplinskaia LE; Vetrov IuD
    Vestn Oftalmol; 2006; 122(6):29-33. PubMed ID: 17217199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Is prevention of diabetes mellitus possible?].
    Lehmann R; Spinas GA
    Ther Umsch; 1994 Oct; 51(10):693-700. PubMed ID: 7839327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Linomide, a new treatment for autoimmune diseases: the potential in type 1 diabetes.
    Slavin S; Sidi H; Weiss L; Rosenman E; Kalland T; Gross D
    Diabetes Metab Rev; 1993 Dec; 9(4):311-5. PubMed ID: 7924828
    [No Abstract]   [Full Text] [Related]  

  • 15. [Specific features of cellular immunity of pulmonary tuberculosis in patients with diabetes mellitus].
    Karachunskiĭ MA; Gergert VIa; Iakovleva OB
    Probl Tuberk; 1997; (6):59-60. PubMed ID: 9503939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Rehabilitation of children and adolescents with diabetes mellitus in sanatoria for children with parents].
    Ivanova LV; Ivanova NV
    Vopr Kurortol Fizioter Lech Fiz Kult; 2002; (6):41-2. PubMed ID: 12592909
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunologic aspects of type I diabetes.
    Dobersen MJ; Chase HP
    Pediatrician; 1983-1985; 12(4):173-8. PubMed ID: 6400449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin D in diabetes mellitus-a new field of knowledge poised for D-velopment.
    Alfonso B; Liao E; Busta A; Poretsky L
    Diabetes Metab Res Rev; 2009 Jul; 25(5):417-9. PubMed ID: 19565622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunomodulation with human recombinant autoantigens.
    Lernmark A; Agardh CD
    Trends Immunol; 2005 Nov; 26(11):608-12. PubMed ID: 16153889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endogenous immune response to glutamic acid decarboxylase (GAD67) in NOD mice is modulated by adjuvant immunotherapy.
    Qin HY; Elliott JF; Lakey JR; Rajotte RV; Singh B
    J Autoimmun; 1998 Dec; 11(6):591-601. PubMed ID: 9878081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.